Breast cancer-specific and overall mortality by current pre-diagnostic and post-diagnostic use of specific statins.

Cohort of all breast cancer patients diagnosed in Finland during 1995–2003.
*Statin types are not mutually exclusive, i.e. person who has used two types of statins (e.g. atorvastatin and simvastatin) is counted as a user in both categories.
†Calculated with Cox regression model adjusted for age, tumor stage and morphology, treatment selection and pre-diagnostic statin use.
Breast cancer-specific and overall mortality by current pre-diagnostic and post-diagnostic use of specific statins.